However, CDR1as was reported to inhibit tumor growth in glioblastoma multiforme by disrupting p53/MDM2 complex formation (Lou et al., 2020), which implies that CDR1as has different effects on cell growth in different cancer types (Figure 2). The gene discussed is LINC00632; the disease is cancer.